The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir
Sh. P. Abdullaev(Russian Medical Academy of Continuous Professional Education), Д. А. Сычев(Russian Medical Academy of Continuous Professional Education), К. Б. Мирзаев(Russian Medical Academy of Continuous Professional Education), Т. Т. Валиев(Ministry of Health), И. И. Темирбулатов(Russian Medical Academy of Continuous Professional Education), А. А. Качанова(Russian Medical Academy of Continuous Professional Education), Elizaveta V. Mikhaylenko(Sechenov University), А. V. Kryukov(Russian Medical Academy of Continuous Professional Education), Н. П. Денисенко(Russian Medical Academy of Continuous Professional Education), С. Н. Тучкова(Russian Medical Academy of Continuous Professional Education)
Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
January 14, 2024
Cited by 0
Related Papers
The Links between Cardiovascular Diseases and Alzheimer's Disease
|Current Neuropharmacology|2020|81
The Dawn of Mitophagy: What Do We Know by Now?
|Current Neuropharmacology|2020|68
Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review
|Advances in Therapy|2020|58
The Effect of Short-Term Physical Activity on the Oxidative Stress in Rats with Different Stress Resistance Profiles in Cerebral Hypoperfusion
|Molecular Neurobiology|2020|19
Mitochondrial Dysfunction in Intensive Care Unit Patients
|Current Pharmaceutical Design|2020|16